Celator Pharmaceuticals Inc (CPXX)

30.24
0.00 (0.00)
Prev Close 30.24
Open 30.25
Day Low/High 30.23 / 30.25
52 Wk Low/High 1.12 / 30.36
Volume 993.56K
Avg Volume 2.94M
Exchange
Shares Outstanding 42.47M
Market Cap 1.28B
EPS -0.60
Div & Yield N.A. (N.A)

Latest News

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Celator Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Celator Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Celator...

Celator Pharmaceuticals® Presented Phase 3 Trial Results In Patients With High-Risk Acute Myeloid Leukemia Demonstrating VYXEOS™ (CPX-351) Significantly Improved Overall Survival

Celator Pharmaceuticals® Presented Phase 3 Trial Results In Patients With High-Risk Acute Myeloid Leukemia Demonstrating VYXEOS™ (CPX-351) Significantly Improved Overall Survival

-- First therapy to demonstrate statistically significant improvement in overall survival and induction response rate in a pivotal Phase 3 trial in high-risk AML -

Ardelyx Has Big Potential

This small-cap company's shares are half where they ended 2015.

'Mad Money' Lightning Round: Be Careful With Fitbit

'Mad Money' Lightning Round: Be Careful With Fitbit

Cramer says Dow Chemical is undervalued and Nokia is never coming back.

Jim Cramer's 'Mad Money' Recap: Here's Why It's Time to Start Buying Stocks

Jim Cramer's 'Mad Money' Recap: Here's Why It's Time to Start Buying Stocks

When investors get complacent, they miss out on great opportunities to buy, Cramer says.

CELATOR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Jazz Pharmaceuticals Plc

CELATOR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Jazz Pharmaceuticals Plc

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Celator...

Lack of Negative Catalyst Vexes Bears

The problem for the bears is that there are still plenty of folks trying to extract some gains from the upside.

Stocks Climb Slightly in May Despite Fed Fears

Stocks Climb Slightly in May Despite Fed Fears

U.S. markets ended May on a positive note, despite fears over the likelihood of a summer rate hike by the Federal Reserve that made trading unpredictable.

Stocks on Track for Mixed May as Dow Loses Gains

Stocks on Track for Mixed May as Dow Loses Gains

Stock are on track for a mixed month as escalating fears over the likelihood of a summer rate hike from the Federal Reserve erases gains for the Dow.

Shareholder Alert: Brower Piven Commences An Investigation Into The Proposed Sale Of Celator Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

Shareholder Alert: Brower Piven Commences An Investigation Into The Proposed Sale Of Celator Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Celator...

Here’s Why Shares of Celator Are Climbing on Tuesday

Here’s Why Shares of Celator Are Climbing on Tuesday

Celator Pharmaceuticals jumped more than 70 percent in Tuesday's trading session after Jazz Pharmaceuticals said it would buy the company for $1.5 billion.

Stocks Waver as Boost in Spending Lifts Rate Hike Chances

Stocks Waver as Boost in Spending Lifts Rate Hike Chances

Stocks fluctuate Tuesday morning as a big boost in consumer spending in April increases the chances the Federal Reserve will implement another rate hike this summer.

This Market Is in No Mood to Worry

Fear of being left out is overwhelming big-picture concerns.

Biotech M&A Waking Up After Long Nap

The uptick in the small- and mid-cap space bodes well for future capital appreciation.

Morning Movers: CPXX, VZ, VLKAY

Celator led the pack of market movers in premarket trading Tuesday, jumping more than 70% off news of a $1.5 billion takeover bid from Jazz Pharmaceuticals.

Stock Futures Higher as Spending Sees Biggest Jump in Seven Years

Stock Futures Higher as Spending Sees Biggest Jump in Seven Years

Stock futures hold slight gains on Tuesday after consumer spending in April shows its best gain since August 2009.

Jazz Pharmaceuticals Strikes Celator Takeover Pact

Jazz Pharmaceuticals Strikes Celator Takeover Pact

The agreement will hand the Dublin company a promising pipeline drug to treat leukemia.

Rev's Forum: The Fed Is the Big Question, While Celator Takes Off

Will the market still brush off worries of an interest rate hike?

Celator Pharmaceuticals (CPXX) Moving On Heavy Pre-Market Trading

Celator Pharmaceuticals (CPXX) Moving On Heavy Pre-Market Trading

Trade-Ideas LLC identified Celator Pharmaceuticals (CPXX) as a pre-market mover with heavy volume candidate

May 31 Premarket Briefing: 10 Things You Should Know

May 31 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are rising slightly Tuesday while European stocks fall as data indicate the eurozone remains in the grip of deflation.

Janet Yellen Could Upset Things Very Easily

Besides today, she has another speech coming up in early June.